| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/21/1994 | CA2101809A1 Cytotoxic drug conjugates for treatment of neoplastic diseases |
| 02/18/1994 | CA2104042A1 Method of treating immunoinflammatory disease |
| 02/17/1994 | WO1994003644A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | WO1994003633A1 Assessment of trans-acting factors allelic variation |
| 02/17/1994 | WO1994003629A1 Monoclonal antibodies specific for 3',6'-isold1 ganglioside |
| 02/17/1994 | WO1994003627A1 Method for design of novel proteins and proteins produced thereby |
| 02/17/1994 | WO1994003618A1 K. lactis transaldolase gene promoter and use thereof |
| 02/17/1994 | WO1994003614A1 Inhibitor resistant serine proteases |
| 02/17/1994 | WO1994003611A2 Ptp-d subfamily of protein tyrosine phosphatases |
| 02/17/1994 | WO1994003609A1 Eucaryotic cells transformed with a mammalian phospholipid kinase or protein kinase and assays using them |
| 02/17/1994 | WO1994003604A1 PfEMP3 MALARIA ANTIGEN, ANALOGS, ANTIBODIES AND USES THEREOF |
| 02/17/1994 | WO1994003603A1 Novel glycoforms of soluble complement receptor 1 |
| 02/17/1994 | WO1994003601A2 Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan |
| 02/17/1994 | WO1994003600A1 Morphogenic protein soluble complex and composition thereof |
| 02/17/1994 | WO1994003598A1 Antiallergic agent |
| 02/17/1994 | WO1994003597A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/17/1994 | WO1994003596A1 Antisense viruses and antisense-ribozyme viruses |
| 02/17/1994 | WO1994003594A1 Androgen regulation with dna sequences of rat probasin gene |
| 02/17/1994 | WO1994003555A1 Antioxidant |
| 02/17/1994 | WO1994003499A1 Auto-cross-linked gellan gum |
| 02/17/1994 | WO1994003494A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | WO1994003493A1 Peptides derived from an immunosuppressive region in the retroviral genome |
| 02/17/1994 | WO1994003492A1 Interleukin-6 variants and uses therefor |
| 02/17/1994 | WO1994003491A1 Amylin muteins |
| 02/17/1994 | WO1994003490A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 02/17/1994 | WO1994003489A1 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| 02/17/1994 | WO1994003488A1 Novel peptide |
| 02/17/1994 | WO1994003487A1 New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
| 02/17/1994 | WO1994003485A1 Peptide lung surfactants and therapeutic combinations |
| 02/17/1994 | WO1994003484A1 Synthetic peptide lung surfactants having covalently bonded antioxidants |
| 02/17/1994 | WO1994003483A1 Endothelin receptor-binding compounds |
| 02/17/1994 | WO1994003482A1 Glycyl-hystidyle-lysine (ghl) derivatives |
| 02/17/1994 | WO1994003481A1 Diamino acid derivatives as antihypertensives |
| 02/17/1994 | WO1994003480A1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents |
| 02/17/1994 | WO1994003479A1 Thrombin receptor antagonists |
| 02/17/1994 | WO1994003478A1 Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen |
| 02/17/1994 | WO1994003469A1 New derivatives of neuraminic acid |
| 02/17/1994 | WO1994003205A1 Hla binding peptides and their uses |
| 02/17/1994 | WO1994003204A1 Improving the body composition of fish via the administration of porcine somatotropin (pst) |
| 02/17/1994 | WO1994003203A1 Alimentary canal cell activator |
| 02/17/1994 | WO1994003202A1 Interleukin-4 stimulated t lymphocyte cell death |
| 02/17/1994 | WO1994003201A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | WO1994003200A1 Morphogen-induced nerve regeneration and repair |
| 02/17/1994 | WO1994003199A1 Method of enhancing differentiation and survival of neuronal precursor cells |
| 02/17/1994 | WO1994003198A1 Human growth hormone aqueous formulation |
| 02/17/1994 | WO1994003197A1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin |
| 02/17/1994 | WO1994003196A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | WO1994003191A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
| 02/17/1994 | WO1994003184A1 Compositions for treating and inhibiting gastric and duodenal ulcers |
| 02/17/1994 | WO1994003181A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver |
| 02/17/1994 | WO1994003158A1 Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 02/17/1994 | WO1994003156A1 Pharmaceutical and/or cosmetic preparation and the use of the preparation |
| 02/17/1994 | WO1994003119A1 Composition of low type iii content human placental collagen |
| 02/17/1994 | WO1994003075A2 Morphogen-enriched dietary composition |
| 02/17/1994 | WO1994003059A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 02/17/1994 | WO1994003055A1 Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv |
| 02/17/1994 | WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/17/1994 | WO1993025577A3 Active component of parathyroid hypertensive factor |
| 02/17/1994 | WO1993020839A3 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality |
| 02/17/1994 | DE4226531A1 Taktventil zur diskontinuierlichen Dosierung eines Volumenstroms Impulse valve for intermittent dosage of a volume flow |
| 02/17/1994 | DE4226373A1 Glyco-proteins derived from Halobacterium salinarium - useful in treatment and prophylaxis of diseases by non-specifically stimulating the immune system |
| 02/17/1994 | CA2489978A1 Human growth hormone aqueous formulation |
| 02/17/1994 | CA2142185A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | CA2141960A1 Hla binding peptides and their uses |
| 02/17/1994 | CA2141847A1 Ptp-d subfamily of protein tyrosine phosphatases |
| 02/17/1994 | CA2141785A1 Diamino acid derivatives as antihypertensives |
| 02/17/1994 | CA2141685A1 Antiallergic composition |
| 02/17/1994 | CA2141678A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | CA2141673A1 Non-peptidyl moiety-conjugated cd4-gamma2 and cd4-igg2 immunoconjugates, and uses thereof |
| 02/17/1994 | CA2141600A1 Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan |
| 02/17/1994 | CA2141588A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | CA2141556A1 Morphogen-enriched dietary composition |
| 02/17/1994 | CA2141447A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | CA2141432A1 Pharmaceutical compositions and use of dilinoleoylphosphatidylcholine (dlpc) for treatment and prevention of cirrhosis and fibrosis in the liver |
| 02/17/1994 | CA2141061A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/17/1994 | CA2140907A1 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| 02/17/1994 | CA2140902A1 K. lactis transaldolase gene promoter and use thereof |
| 02/17/1994 | CA2139854A1 Peptidyl 4-amino-2, 2-difluoro-3-oxo-1, 6-hexanedioic acid derivatives as antiinflammatory agents |
| 02/17/1994 | CA2139668A1 Composition of low type iii content human placental collagen |
| 02/17/1994 | CA2120511A1 Pharmaceutical and/or cosmetic composition and the use thereof |
| 02/17/1994 | CA2119873A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enyzme for its preparation |
| 02/16/1994 | EP0583074A2 Angiotensin converting enzyme inhibitor and method for preparing same |
| 02/16/1994 | EP0583050A2 Recombinant stimulating factor of the neu receptor |
| 02/16/1994 | EP0582933A1 Therapeutic system for the parenteral administration of hematopoietic growth factors |
| 02/16/1994 | EP0582932A1 Therapeutic system for the parenteral administration of hematopoietic growth factors |
| 02/16/1994 | EP0582796A1 Promotor for expression and use thereof |
| 02/16/1994 | EP0582631A1 S-nitrosothiols as smooth muscle relaxants and therapeutic uses thereof |
| 02/16/1994 | EP0500589B1 Purified protein and bioactive pharmaceutical |
| 02/16/1994 | EP0449897B1 A pure factor i protein and a process for producing said protein |
| 02/16/1994 | EP0382814B1 Nisin compositions for use as enhanced, broad range bactericides |
| 02/16/1994 | EP0343241B1 A method of inhibiting platelet dependent arterial thrombosis |
| 02/16/1994 | CN1082112A Derivatives of adipogenesis inhibitory factor, their preparation and their use |
| 02/16/1994 | CN1082052A Preparation and application of memory enhancing peptide (MEP) |
| 02/16/1994 | CN1082035A Inhibitors of hiv protease useful for the treatment of aids |
| 02/16/1994 | CN1082027A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/16/1994 | CN1081909A Methods and compositions for the treatment of diseases with interferon while reducing side effects |
| 02/15/1994 | US5286904 Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine |
| 02/15/1994 | US5286852 Antibodies specific towards HIV-1 gp 48 |
| 02/15/1994 | US5286851 For selective binding to doxorubicin(and derivatives) |
| 02/15/1994 | US5286850 Antibody DTPA-type ligand conjugates |